CINECA IRIS Institutional Research Information System

CERUTI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.439
EU - Europa 4.614
AS - Asia 1.982
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 4
SA - Sud America 3
Totale 12.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.407
CN - Cina 1.001
IE - Irlanda 772
IT - Italia 728
DE - Germania 625
SE - Svezia 587
FI - Finlandia 443
KR - Corea 414
UA - Ucraina 407
JP - Giappone 295
FR - Francia 289
VN - Vietnam 208
PL - Polonia 178
GB - Regno Unito 177
AT - Austria 143
DK - Danimarca 120
BE - Belgio 48
IN - India 31
RU - Federazione Russa 30
CA - Canada 29
NL - Olanda 27
SN - Senegal 23
EU - Europa 13
UZ - Uzbekistan 12
IR - Iran 9
GR - Grecia 8
ZA - Sudafrica 7
CZ - Repubblica Ceca 4
ES - Italia 4
HU - Ungheria 4
RO - Romania 4
AU - Australia 3
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CH - Svizzera 2
MX - Messico 2
MY - Malesia 2
RS - Serbia 2
SG - Singapore 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
CR - Costa Rica 1
DZ - Algeria 1
HK - Hong Kong 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
SI - Slovenia 1
TW - Taiwan 1
Totale 12.092
Salva come PNG Salva come JPEG
Città #
Dublin 771
Chandler 747
Beijing 742
Ann Arbor 730
Jacksonville 422
Dearborn 300
Princeton 234
Houston 183
Boston 181
Dong Ket 177
Warsaw 174
Wilmington 171
Villeurbanne 156
Fairfield 151
Medford 146
Vienna 143
Torino 127
Woodbridge 115
Nyköping 95
Ashburn 87
Munich 76
Fremont 74
Boardman 65
Seattle 63
Milan 59
Cambridge 54
Frankfurt am Main 53
Pisa 45
Brussels 44
Hefei 32
Falls Church 31
Norwalk 28
Kunming 26
Verona 24
Redwood City 23
Nanjing 21
Rome 20
Guangzhou 18
Washington 17
Düsseldorf 15
Nanchang 15
Buffalo 14
Cimitile 14
Hebei 12
San Mateo 12
Hangzhou 11
Toronto 11
Zhengzhou 11
Harbin 9
Chongqing 8
Palermo 8
Phoenix 8
Shanghai 8
Wuhan 8
Fuzhou 7
Hanover 7
Johannesburg 7
Lachine 7
Philadelphia 7
San Diego 7
Tulsa 7
Jinan 6
Moscow 6
Paderno Dugnano 6
Shenyang 6
Bari 5
Dallas 5
Helsinki 5
Loreto 5
Mountain View 5
Napoli 5
Shenzhen 5
Ardabil 4
Brescia 4
Changsha 4
Lavagna 4
Leawood 4
London 4
Monmouth Junction 4
Redmond 4
Ruda Śląska 4
Turin 4
University Park 4
Bologna 3
Budapest 3
Castello di Godego 3
Des Moines 3
Hamilton 3
Iesi 3
Kharkiv 3
Ningbo 3
Ottawa 3
Pavia 3
Radolfzell 3
Salerno 3
San Giuliano Milanese 3
Stavanger 3
Sydney 3
Trieste 3
Al Ain 2
Totale 6.991
Salva come PNG Salva come JPEG
Nome #
Carbammati lipidici di farmaci antitumorali. 382
Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase 201
Farmaci macromolecolari: veicolazione e direzionamento mediante albumina umana 187
Study of (1-alkoxyethyl)diphenylphosphine oxides. I. Syntheses and structural analyses of phenylethoxy, methoxy and isopentyloxy derivatives. 168
Robinia “Georgia da Torino”. 152
1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis[1,2,4]triazolo[4,3-a:3’,4’-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties 151
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase. 145
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells 142
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 141
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 140
10 and 19-azasqualene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase from pig liver. 135
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase 134
Comparison of experimental and molecular modelling results on phosphine oxides. 128
A Simple Synthesis and some Chemical Properties of Benzo-1,4-dithiafulvenes 119
Study of (1-alkoxyethyl)diphenylphosphine oxides. II. Conformational analysis by theoretical calculations. 117
Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy 116
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases 115
Study of (1-alkoxyethyl)diphenylphosphine oxides. III. Nuclear magnetic resonance analysis. 112
Study of (1-alkoxyethyl)diphenylphosphine oxides. IV. Conclusive conformational study by NMR and molecular mechanics calculations. 110
Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as Inhibitors of Liver and Yeast Oxidosqualene Cyclase. 109
[Antiproliferative effect of an extract of Aspergillus terreus] 107
Studio del metabolismo in vivo nel ratto dell'antiparkinson Budipina. 101
Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry 98
Structure and reactivity of the dammarenyl cation: configurational transmission in triterpene synthesis 94
Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique 93
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 92
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 90
Sintesi di aldeidi per omologazione di composti carbonilici, via 1,4-benzoditiafulveni. 90
Synthesis and biological activity of 22,23-epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide - lanosterol cyclase. 88
An NMR and molecular mechanics study of squalene and squalene derivatives 87
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis. 86
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface 80
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 77
Sintesi di inibitori suicidi dello squalene 2,3-epossido ciclasi. 77
2,3-oxidosqualene cyclase and squalene epoxidase: enzymology, mechanism and inhibitors 77
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors 77
The squalene-2,3-epoxide cyclase as a model for the development of new drugs. 76
New DSPE-PEG-Folate conjugates for liposomal drug targeting 76
The metabolic fate of the anti-parkinsonian drug budipine in rats. 73
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors. 73
Azasqualeni N-ossidi e bis-azasqualeni, inibitori dell'enzima squalene epossido ciclasi. 73
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 73
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 72
Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae. 72
Total synthesis of the hypocholesterolemic and antifungal drug 10-azasqualene 2,3-epoxide, the first non-cyclized analogue of the C-8 carbonium ion formed during squalene epoxide cyclization. 72
Bis(2-Acyloxy or Aroylxybenzenethiolates)Mercury (II) as Inhibitors of “Fusarium” 71
Synthesis, characterization and biological activity of new cationic lipids active for gene transfection. 71
2-Aza-2,3-dihydrosqualene: biodistribution and pharmacokinetic properties in mice. 71
N-oxide as a potential function in the design of enzyme inhibitors. Application to 2,3-epoxysqualene-sterol cyclases. 71
A new "solid phase" procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates). 71
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase. 70
Synthesis of HEI analogues of the C-20 carbocation forming during lanosterol biosynthesis, as hypocholesterolemics. 70
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase. 70
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 69
2,3-oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 69
The in vitro metabolism of 1,3-thiazolidine derivatives of theophylline: a study on structure-metabolism correlation. 69
2,3-Oxidosqualene cyclase and squalene epoxidase as target enzymes for the development of new sterol biosynthesis inhibitors 68
2,3,4,5-Tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 68
2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase. 67
Synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 67
Synthesis of tritium-labelled 19-azasqualene 2,3-epoxide and derivatives, as probes to study their hypocholesterolemic activity. 67
Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives. 66
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 66
Antifungal and cytotoxic activiti of two inhibitors of 2,3-oxidosqualene cyclase 66
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 65
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase 65
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. 64
22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase. 64
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 64
Synthesis of new gemcitabine prodrugs for liposome and nanoparticle encapsulation 63
Sostanze mutagene e cancerogene in funghi del genere Agaricus. 62
A convenient synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 62
Biocompatible micelles based on amphiphilic polyaspartamide-squalene derivatives as potential colloidal drug carriers. 61
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study. 61
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 61
(E) and (Z)-29-methylidene-2,3-oxidosqualene as stereospecific mechanism-based inhibitors of 2,3-oxidosqualene cyclase. 60
Rational inhibition of sterol biosynthesis: new time-dependent inhibitors of 2,3-oxidosqualene cyclase. 60
Azasqualene alcohol and derivatives. New selective inhibitors of 2,3-oxidosqualene cyclase. 60
Studio comparato dell'attività inibitoria di derivati squalenoidi acetilenici ed allenici, nei confronti dell'enzima squalene epossidasi e delle monoossigenasi P-450 dipendenti. 60
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids 59
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 59
Total synthesis and inhibition of sterol biosynthesis by 10-azasqualene 2,3-epoxide, a high-energy intermediate analogue 58
Metabolismo ossidativo di funzioni acetaliche e tioacetaliche cicliche: studio della correlazione struttura metabolismo. 58
Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique 57
Studio del metabolismo del 7-(1,3-ditiolan-2-ilmetil)teofillina, un nuovo farmaco ad attività antibroncospastica e mucolitica. 57
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 56
Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives. 56
Incorporation of lipophilic gemcitabine prodrugs in liposomes 56
Synthesis and inhibition of cholesterol biosynthesis by azasqualene alcohol and derivatives. 55
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity. 55
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes. Evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage. 55
Sintesi ed attività biologica di azasqualeni, bis-azasqualeni e derivati. 55
Preparation, characterization, cytotoxicity and pharmacokinetcs of liposomes containing lipophilic gemcitabine prodrugs 54
2-Aza-2,3-dihydrosqualene and its N-oxide as inhibitors of sterol biosynthesis in bramble cell suspension cultures. 53
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 53
An NMR study of 2-aza and 19-azasqualene derivatives. Primo Congresso Congiunto Italiano-Svizzero di Chimica Farmaceutica, 53
Synthesis of new inhibitors of oxidosqualene cyclase. 53
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives. 52
An NMR and molecular mechanics study of squalene and squalene derivatives. 52
Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase. 52
Totale 8.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.964
article - articoli 0
book - libri 0
conference - conferenze 10.286
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019868 0 0 0 23 29 172 49 146 49 57 243 100
2019/20202.052 75 130 229 127 114 345 275 89 266 172 143 87
2020/20211.410 182 49 86 70 127 73 117 37 140 96 126 307
2021/20221.901 71 56 66 139 114 65 144 138 60 140 391 517
2022/20232.394 295 133 37 235 212 697 288 125 215 21 102 34
2023/2024405 163 184 55 3 0 0 0 0 0 0 0 0
Totale 12.705